Advances and Obstacles in Homology-Mediated Gene Editing of Hematopoietic Stem Cells.
Advances and Obstacles in Homology-Mediated Gene Editing of Hematopoietic Stem Cells.
复制标题
DOI:
10.3390/jcm10030513
复制
发表时间:
2021-02-01
影响因子:
3.9
通讯作者:
Larochelle A
中科院分区:
文献类型:
--
作者:
Salisbury-Ruf CT;Larochelle A
Homology-directed gene editing of hematopoietic stem and progenitor cells (HSPCs) is a promising strategy for the treatment of inherited blood disorders, obviating many of the limitations associated with viral vector-mediated gene therapies. The use of CRISPR/Cas9 or other programmable nucleases and improved methods of homology template delivery have enabled precise ex vivo gene editing. These transformative advances have also highlighted technical challenges to achieve high-efficiency gene editing in HSPCs for therapeutic applications. In this review, we discuss recent pre-clinical investigations utilizing homology-mediated gene editing in HSPCs and highlight various strategies to improve editing efficiency in these cells.
登录
查看更多内容
影响因子:
5.9
作者:
Brown A;Pospiech J;Eiwen K;Baker DJ;Moehrle B;Sakk V;Nattamai K;Vogel M;Grigoryan A;Geiger H
通讯作者:
Geiger H
影响因子:
16.6
作者:
Carlson-Stevermer J;Abdeen AA;Kohlenberg L;Goedland M;Molugu K;Lou M;Saha K
通讯作者:
Saha K
影响因子:
14.8
作者:
Bak RO;Dever DP;Porteus MH
通讯作者:
Porteus MH
影响因子:
15.1
作者:
Chou, Shih-Jie;Yang, Peng;Chiou, Shih-Hwa
通讯作者:
Chiou, Shih-Hwa
DOI:
10.1073/pnas.1818461116
发表时间:
2019-10-15
影响因子:
11.1
作者:
Acharya, Sundaram;Mishra, Arpit;Chakraborty, Debojyoti
通讯作者:
Chakraborty, Debojyoti